#METS SCORE CALCULATOR UPDATE#

Diagnosis-specific prognostic factors, indices and treatment outcomes for patients with newly-diagnosed brain metastases: a multi-institutional analysis of 4259 patients. The Graded Prognostic Assessment (GPA): A new diagnosis-specific prognostic index for women with breast cancer and brain metastases. Summary report on the Graded Prognostic Assessment (GPA): an accurate and facile diagnosis-specific tool to estimate survival, guide treatment and stratify clinical trials for patients with brain metastases. Effect of tumor subtype on survival and the Graded Prognostic Assessment for patients with breast cancer and brain metastases. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients with Adenocarcinoma of the Lung and Brain Metastases.

#METS SCORE CALCULATOR UPDATE#

Estimating Survival in Patients with Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer using Molecular Markers (Lung-molGPA). The Prognostic Value of BRAF, cKIT and NRAS Mutations in Melanoma Patients with Brain Metastases. Estimating Survival in Melanoma Patients with Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). The Effect of Targeted Therapies on Prognostic Factors, Patterns of Care and Survival in Patients with Renal Cell Carcinoma and Brain Metastases. Estimating Survival for Renal Cell Carcinoma Patients with Brain Metastases: An Update of the Renal Graded Prognostic Assessment (Renal-GPA). Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases have we made progress. Clinical and Translational Radiation Oncology 2019 Sep 18:39-45. Estimating Survival in Patients with Gastrointestinal Cancers and Brain Metastases: An Update of the Graded Prognostic Assessment for Gastrointestinal Cancers (GI-GPA). Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases from 1985 to Today. Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival. Survival in Patients with Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors. The GPA will help patients and their doctors select appropriate treatment and is also used to stratify clinical trials.ġ7. The results have been published in peer-reviewed medical journals and independently validated. These indices have been developed and updated over the past decade. Survival and the factors that predict survival vary by diagnosis and the molecular profile of the patient's tumor. The Graded Prognostic Assessment (GPA) estimates survival for patients with brain metastases.

Mets score calculator